快速检索:        
    
在线办公系统
在线期刊
下载专区
排行榜
友情链接
扫描微信二维码,获取更多信息
王怀璋,林焯唐.抗癌宝口服液治疗中晚期恶性肿瘤103例临床观察[J].中国中西医结合杂志,1997,(12):730-732
抗癌宝口服液治疗中晚期恶性肿瘤103例临床观察
Clinical Study on Effect of Kang’aibao Oral Liquid in Treating 103 Malignant Tunmor Patients
免费下载全文  查看/发表评论  下载PDF阅读器
  
DOI:
中文关键词:  中晚期恶性肿瘤  抗癌宝口服液  生存时间  生存质量
英文关键词:malignant tumor of middle or advanced stage  Kangaibao oral liquid  survival time  quality of survival
基金项目:
作者单位
王怀璋 河南省肿瘤医院 
林焯唐 河南省肿瘤医院 
摘要点击次数: 1445
全文下载次数: 1053
中文摘要:
      目的:观察中药抗癌宝口服液(简称抗癌宝)治疗中晚期恶性肿瘤临床效果。方法:103例患者随机分为抗癌宝观察组与化疗对照组,对两组疗效作比较。结果:观察组患者免疫功能,近期有效率(CR+PR),生存质量,1、2、3年生存期及中位生存时间,癌胚抗原下降水平,明显高于对照组,且有显著性差异。结论:抗癌宝具有抑制肿瘤生长,延长生存时间,提高生存质量之效。
英文摘要:
      Objective: To observe the clinical efficacy of Kangaihao oral liquid(KABOL), a Chinese herbal Preparation in treating malignant turmor of middle or advanced stage. Methods:A comparative study was done by observing the effect of 103 patients treated with KABOL, and another 90 patients treated with chemotherapy in the same period were taken as a control group for comparison. Results : The immunologic function, short-term effective rate(complete relieved rate and partial relieved rate), survival quality, 1-, 2-and 3-year survival rate, median suvival time,and the CEA declining rate of the KABOL group were significantly higher than thine of the control group. Conclusions: KABOL has the effects of inhibiting tumor growth, prolonging the survival time and improving the quality ofsurvival of tumor patient.
关闭